European Archives - Page 413 of 1266 - European Medical Journal

Roche's obesity drug shows promising results at Phase I

Another obesity drug could be on its way to the market after Roche announces positive results for its drug in a phase I trial.

MRI Scans Predict Atrophy in Parkinson’s Disease

Researchers have discovered that the progression of grey matter atrophy in the brain of patients with mild Parkinson’s disease can be predicted using MRI.

AI Model Bias in Diagnostic Medical Imaging

Researchers investigate the impact of demographic predictions on AI diagnostic fairness, revealing significant disparities for women and Black patients in chest X-ray screenings.

New Link Between Immunosuppressant Agents and Cancer in Kidney Transplant Recipients

Immunosuppression agent exposure is linked to an increased incidence of primary malignant neoplasms in kidney transplant recipients, and this association varies by age and sex.

SOHO 2024 Interview: Guillermo Garcia-Manero

One of the primary tasks of the President of SOHO is to prepare the Annual Meeting scheduled for the first week of September in Houston…

AZ’s Stefan Woxström on why without health, we don’t have anything

Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, unpicks the current small molecule funding landscape, how to improve incentives to invest in rare diseases and more.

Gilead Prevention Symposium at AIDS 2024

Improved HIV prevention awareness, education, and access are essential for protecting those who might benefit and helping tackle the…

Traces of Toxic Metals Found in Tampons

Tampons have been found to contain toxic metals like lead, arsenic, and cadmium, according to a new study published by the University of California, Berkeley.

Gut Microbes and Viruses Linked to Type 2 Diabetes

A recent study identified specific bacterial strains and viruses that can cause changes in the gut microbiome, potentially increasing the risk for type 2 diabetes.

β-Lactam De-escalation Cuts Sepsis Antibiotic Resistance Risk

A recent study found that de-escalating beta-lactam antibiotics in hospitalized sepsis patients significantly reduced the risk of developing new Gram-negative antibiotic resistance.